25-03-25 Alerts on Bio Vitos Pharma withdrawn RE
25-03-17 Bio Vitos Pharma is delisted from First North with last trading day April 11 FW
25-02-28 Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
24-11-15 Bio Vitos Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-11-13 Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider AQ
24-09-12 Bio Vitos Pharma signs exclusive distribution agreement in the Balkans FW
24-08-30 Bio Vitos Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-13 Bio Vitos Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-02-14 Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
24-02-14 Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
24-02-12 Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes MT
24-02-12 KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer AQ
24-02-12 KFUM Kalmar and Bio Vitos Pharma Sign Collaboration Agreement to Conduct Research Study on Succifer CI
23-12-20 The European Patent Office EPO grants patent that is important to Bio Vitos Pharma AQ
23-12-20 The European Patent Office EPO Grants Patent to Bio Vitos Pharma AB CI
23-12-06 Hemcheck Sweden AB will Change its Ticker to BIOVIT from HEMC CI
23-12-06 Hemcheck Sweden AB will Change its Name to Bio Vitos Pharma AB CI
23-11-16 Bio Vitos Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-10-20 Hemcheck completes the transaction with Bio Vitos AQ
23-08-30 Bio Vitos Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-05-15 Hemcheck has received a first order from its distributor Astemed AQ
23-05-15 Hemcheck Sweden AB Receives A First Order from Its Distributor Astemed CI
23-05-09 Hemcheck Sweden AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-05-04 Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement AQ
23-04-26 Additional follow up order from the Foundation for Innovative New Diagnostics (FIND) AQ

Become a member to access more news

New member
No results match your criteria